|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-6-23
|
|
pubmed:abstractText |
Treatment with somatostatin analogues (SA) not only inhibits GH secretion but may also impair insulin secretion. In order to evaluate the influence of SA on glucose metabolism, we investigated insulin resistance (IR) and beta-cell function, using the recommended combination of homeostatic model assessment of IR (HOMA-IR) and beta-cell function (HOMA-beta).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
155
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16793952-Acromegaly,
pubmed-meshheading:16793952-Adult,
pubmed-meshheading:16793952-Aged,
pubmed-meshheading:16793952-Body Mass Index,
pubmed-meshheading:16793952-Cross-Sectional Studies,
pubmed-meshheading:16793952-Female,
pubmed-meshheading:16793952-Gels,
pubmed-meshheading:16793952-Glucose Tolerance Test,
pubmed-meshheading:16793952-Humans,
pubmed-meshheading:16793952-Insulin,
pubmed-meshheading:16793952-Insulin Resistance,
pubmed-meshheading:16793952-Insulin-Secreting Cells,
pubmed-meshheading:16793952-Male,
pubmed-meshheading:16793952-Middle Aged,
pubmed-meshheading:16793952-Peptides, Cyclic,
pubmed-meshheading:16793952-Prospective Studies,
pubmed-meshheading:16793952-Somatostatin
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly.
|
|
pubmed:affiliation |
Medizinische Klinik Innenstadt, Department of Endocrinology, University of Munich, Munich, Germany. birgit.steffin@med.uni-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
